Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

Zhang, Lili; Awadalla, Magid; Mahmood, Syed; Nohria, Anju; Hassan, Malek; Thuny, Franck; A. Zlotoff, Daniel; Murphy, Sean; R. Stone, James; Lauren Alexandra Golden, Doll; M. Alvi, Raza; Rokicki, Adam; Jones‐O’Connor, Maeve; V. Cohen, Justine; Heinzerling, Lucie; P. Mulligan, Connor; Armanious, Merna; Barac, Ana; J. Forrestal, Brian; J. Sullivan, Ryan; Y. Kwong, Raymond; H. Yang, Eric; Damrongwatanasuk, Rongras; L. Chen, Carol; Gupta, Dipti; Constantin Kirchberger, Michael; J. Moslehi, Javid; R. Coelho‐Filho, Otávio; Ganatra, Sarju; A. Rizvi, Muhammad; Sahni, Gagan; G. Tocchetti, Carlo; Mercurio, Valentina; Mahmoudi, Michael; P. Lawrence, Donald; L. Reynolds, Kerry; W. Weinsaft, Jonathan; John Baksi, A.; Éderhy, Stéphane; D. Groarke, John; R. Lyon, Alexander; G. Fradley, Michael; Thavendiranathan, Paaladinesh; G. Neilan, Tomas

doi:10.1093/eurheartj/ehaa051

Public

Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis

Published in European Heart Journal • Jan 21, 2020

Authors:

Lili Zhang

Magid Awadalla

Syed Mahmood

Abstract

AIMS: Myocarditis is a potentially fatal complication of immune checkpoint inhibitors (ICI). Sparse data exist on the use of cardiovascular magnetic resonance (CMR) in ICI-associated myocarditis. In this study, the CMR characteristics and the association between CMR features and cardiovascular event...

Subject

Medicine

Myocarditis

Ejection fraction

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!